MUMBAI, India, Jan. 31 -- Intellectual Property India has published a patent application (202417102707 A) filed by Remegen Co. Ltd., Shandong, China, on Dec. 24, 2024, for 'taci-fc fusion protein liquid pharmaceutical preparation.'
Inventor(s) include Xu, Qiaoyu; Bao, Qianjing; Li, Qi; Zhao, Yating; and Ma, Shuonan.
The application for the patent was published on Jan. 31, under issue no. 05/2025.
According to the abstract released by the Intellectual Property India: "A liquid pharmaceutical preparation. The present invention particularly relates to a liquid pharmaceutical preparation of a TACI-FC fusion protein and belongs to the field of drugs against autoimmune diseases. The pharmaceutical preparation can improve the stability of the T...